From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Lab-on-a-Chip Technology Development for Intelligence Applications

by Global Biodefense Staff
June 7, 2013

IARPA - Intelligence Advanced Research Projects AgencyThe U.S. Intelligence Advanced Research Projects Activity (IARPA) is seeking information on the current state of the art and challenges in the area of lab-on-a-chip (LOC) technology. 

IARPA is interested in understanding the intelligence value of human physiological changes associated with involvement in chemical and biological weapons manufacture and materials handling reflected through omni-omic response signatures based on immunological, transcriptional, genomic, proteomic, metabolomic, epigenetic and microbiomic characteristics.

The human adaptive immune system is known to carry a long-term memory of exposure to molecules derived from the chemical constituents of pathogenic organisms and viruses. Human immune memory resides in T and B lymphocyte memory cells, and also in plasma cells that secrete circulating antibodies into the bloodstream directed against specific antigens. The adaptive immune system is purposefully stimulated by vaccines, which are designed to provoke lasting responses that can lead to disease resistance. Immune memory, whether natural or by vaccination, can be extremely long-lived. 

IARPA is interested in the development of portable LOC platforms able to provide simultaneous rapid and reliable detection, analysis, and read-out of chemical and biological exposure omni-omic signatures in less than ten minutes. Achieving this goal will require autonomous microfluidic processing methods to take a raw human body fluid sample in order to extract and subsequently analyze its relevant constituents for subsequent biochemical analysis of proteins, cells, nucleic acids, etc. IARPA therefore seeks innovative approaches directed toward achieving an ability to extract large and diverse types of protein, cellular, and nucleic acid information from small quantities (<100 mL) of actual human fluids. 

Approaches to realizing integrated LOC platforms capable of performing meaningful sample clean-up, extractions, and subsequent multiplexed bioassay analysis are also sought.

Further details are available under Solicitation Number: IARPA-RFI-13-04 “Laboratory-on-a-Chip for Multiplexed Bioassay Analysis”.  The response deadline is July 5, 2013.

From Our Partners
Tags: Chemical DetectionRFI

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC